Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS, ACTG A5257 Team
Ann Intern Med. 2014 161 (7): 461-71

PMID: 25285539 · PMCID: PMC4412467 · DOI:10.7326/M14-1084

MeSH Terms (23)

Adenine Adult Atazanavir Sulfate Darunavir Deoxycytidine Drug Combinations Drug Therapy, Combination Emtricitabine Female HIV-1 HIV Infections HIV Protease Inhibitors Humans Male Oligopeptides Organophosphonates Pyridines Reverse Transcriptase Inhibitors RNA, Viral Sulfonamides Tenofovir Therapeutic Equivalency Viral Load

Connections (1)

This publication is referenced by other Labnodes entities: